查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
语音/言语生物标记市场 - 全球及区域分析：按平台类型、指示类型、应用类型、最终用户及区域 - 分析与预测（2025-2035）
市场调查报告书
商品编码
1802931

语音/言语生物标记市场 - 全球及区域分析：按平台类型、指示类型、应用类型、最终用户及区域 - 分析与预测（2025-2035）

Voice/Vocal Biomarker Market - A Global and Regional Analysis: Focus on Platform Type, Application, Indication, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 131 Pages | 商品交期: 1-5个工作天内

价格

声音/声音生物标记是指源自人类声音特征的生物标誌物的开发、商业化和应用，以检测、监测和预测健康状况。

语音/声音生物标记是数位生物标记的子集，是可测量的声音特征，例如音高、音调、频率、幅度、语速和震颤，与生理或病理状况相关，从而实现非侵入性诊断和监测。语音/声音生物标记市场包括软体平台、阿兹海默症演算法、硬体诊断工具以及整合远距医疗解决方案，这些解决方案可捕获和分析语音数据以识别疾病的早期征兆，例如神经系统疾病（例如帕金森氏症、阿兹海默症）、精神远端医疗状况（例如忧郁症、焦虑症）、呼吸系统疾病、心血管疾病和认知能力下降。它还涵盖健康、认知健身、国防和职业健康的应用。该市场的成长得益于技术进步、对远距医疗解决方案日益增长的需求以及语音分析与传统诊断方法相比提供快速、可扩展且经济高效的筛检的能力。

主要市场统计数据
预测期 2025-2035
2025年评估 12.435亿美元
2035年的预测 53.977亿美元
复合年增长率 15.81%

市场介绍

全球语音/言语生物标记市场预计将大幅扩张，到 2035 年将达到 53.977 亿美元。

音频/声音生物标记是一种诊断和监测各种健康状况的全新创新方法，主要透过分析语音模式和声音来实现。随着人工智慧 (AI)、机器学习和自然语言处理 (NLP) 的进步，诊断工具变得更加精准、非侵入式，该领域正在迅速发展。

语音和语音生物标记市场中的公司，包括 Sonde Health、Canary Speech 和 Winterlight，正在利用人工智慧主导的演算法分析语音模式，以检测神经系统、精神系统和认知障碍。这些解决方案评估音高、音调、节奏和速度等语音特征，以识别阿兹海默症、帕金森氏症、忧郁症和焦虑症等疾病的早期征兆。

语音/言语生物标记物正越来越多地被用于监测认知障碍和其他神经系统疾病。能够检测语音和言语模式的细微变化，有助于早期疗育并更准确地追踪病情进展，从而显着改善失智症和其他与老龄化相关的认知障碍的管理。

声音生物标誌物技术的一大优势在于其非侵入性。与需要侵入性操作或大量检测的传统诊断工具不同，声音生物标记利用简短的录音（通常仅 30-40 秒）来检测健康问题的早期指标，这使得其易于进行持续监测，尤其是在偏远地区。

语音/语音生物标记市场的主要企业正在建立策略伙伴关係关係，以增强自身能力并扩大市场份额。例如，Sonde Health 与高通合作，将其语音生物标记技术整合到行动平台，从而实现基于设备的日常健康监测。此外，Winterlight 被 Cambridge Cognition 收购，也促使人们越来越重视透过语音分析来侦测认知障碍。

音频生物标记技术与医疗保健系统的整合正变得越来越广泛，并应用于远端医疗、心理健康和认知健康监测。这些工具越来越多地用于临床环境、患者健康计划和研究，以经济高效且及时的方式追踪健康状况并检测疾病的早期症状。

由于对创新非侵入式诊断解决方案的需求不断增长，语音/声音生物标记市场正在迎来大量投资。预计未来几年，全球语音/声音生物标记市场将继续快速扩张，其应用范围将超越神经和心理健康领域，扩展到慢性阻塞性肺病 (COPD) 等慢性疾病以及压力水平检测。

儘管语音生物标记前景光明，但人们对资料隐私和语音资料的伦理使用仍心存疑虑。由于这些技术会收集个人健康的敏感讯息，因此《一般资料保护规范》(GDPR) 和《健康保险流通与责任法案》(HIPAA) 等法规对于隐私权保护至关重要。该领域的公司致力于确保其解决方案符合资料保护法，并确保用户资料得到安全处理。

摘要，全球语音/言语生物标记市场定位于医疗保健领域的变革性工具，为各种健康状况的早期检测和持续监测提供非侵入性、便捷且可扩展的解决方案。随着技术的进步，语音生物标记融入常规健康应用，有望显着改善患者预后并提高医疗效率。

语音/语音生物标记物市场正日益被用于监测和诊断各种疾病，包括神经退化性疾病（如帕金森氏症和阿兹海默症）、精神疾病（如忧郁症和焦虑症）以及呼吸系统疾病（如气喘和慢性阻塞性肺病）。例如，某些语音变化可能预示着早期帕金森氏症，而这种疾病传统上很难诊断。

基于语音的身份验证：在安全和身份验证至关重要的行业中，语音生物标记用于语音生物识别技术。语音生物辨识技术透过分析人的声音并检查其独特特征（例如口音、语调和说话节奏）来验证身份。它广泛应用于银行、通讯和政府部门。

影响：启用免持身分验证可提高安全性、减少诈欺并改善使用者体验。

在客户支援、客服中心和虚拟助理（如 Alexa 和 Siri）中，语音生物标记可以帮助检测沮丧、快乐和压力等情绪，使企业能够根据客户的情绪状态定制回应或将客户转介给专门的代理商。

市场区隔

细分一：依平台类型

  • 云端基础
  • 基于网路

按平台类型划分，云端基础将继续成为全球语音/语音生物标记市场中的领先细分市场，到 2024 年将占据 79.99% 的市场占有率，预计在 2025-2035 年预测期内的复合年增长率为 16.0%。

全球语音/语音生物标记市场中的云端基础平台正在改变语音资料的收集、储存、处理和分析方式。这些平台提供处理大量语音数据和应用人工智慧演算法进行诊断和监控所需的基础设施和运算能力。用于语音生物标记分析的云端基础平台的出现正在再形成健康诊断和远端患者监护的格局。这些平台利用人工智慧和机器学习的力量来解读语音数据，并将声音特征转化为可操作的健康洞察。利用可扩展的云端基础设施可以实现即时、远端和大规模分析，从而提高临床医生、研究人员和数位健康创新者的可近性。

细分2：依适应症类型

  • 神经系统疾病
  • 精神疾病
  • 呼吸系统疾病
  • 心血管疾病
  • 其他的

从适应症类型来看，全球语音/声音生物标记市场主要由精神健康障碍细分市场驱动，2024 年该细分市场占据 33.51% 的市场占有率。由于对情绪和心理健康非侵入式即时监测的需求日益增长，精神健康障碍适应症在语音/声音生物标记市场中占据主导地位。语音分析可以透过分析音调、音高和说话模式来检测压力、焦虑、忧郁症和其他心理健康状况。例如，Ellipsis Health 等公司开发了人工智慧平台，可透过语音记录评估心理健康状况，从而实现及时干预并改善心理健康服务的可及性。这种方法因其易用性和扩充性而越来越受欢迎。

细分 3：按应用程式类型

  • 诊断
  • 监控
  • 临床研究
  • 其他的

从应用类型来看，全球语音/声音生物标记市场由诊断驱动，占据主导地位。声带生物标记市场的诊断应用受到该技术的非侵入性、检测疾病早期征兆的能力以及在持续监测患者健康方面的作用的驱动。随着人工智慧、机器学习和远距医疗的进步，语音生物标记提供了一种经济高效、可扩展且易于获取的解决方案，提高了疾病检测的准确性和及时性，尤其是在神经系统和呼吸系统疾病方面。随着临床检验的进展以及该技术被整合到医疗保健系统中，语音生物标记的诊断应用预计将进一步扩展，为患者和医疗保健提供者带来显着的益处。

第 4 类：按最终用户

  • 医院
  • CRO
  • 研究所

从终端用户来看，全球语音和言语生物标记市场将由医院和诊所主导，到2024年将占据47.02%的市场份额。医院在语音生物标记市场占据主导地位，这得益于以下几项战略属性：专注于诊断、拥有庞大的数据存储库、精通监管框架、拥有雄厚的资金支持以及在医疗保健网络中享有的信任。医院拥有先进的基础设施、跨部门的协同效应以及接触大量患者群体的优势，使其成为语音生物标誌物创新开发、检验和商业化的首选合作伙伴。随着这些技术不断发展和成熟，医院将继续引领这一新兴领域的临床应用和创新。

细分5：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
  • 中东和非洲

全球语音和言语生物标记市场在亚太地区正在迅速扩张。预计亚太地区语音/语言生物标记市场将经历强劲成长，尤其得益于人工智慧和机器学习在行动医疗设备、穿戴式装置和远端医疗服务中的整合。然而，为了确保长期永续性和广泛应用，需要解决法律规范和资料隐私问题。

对于亚太国家而言，中国凭藉其庞大的人口和快速的技术采用占据该地区最大的市场占有率，而印度则由于医疗保健投资的增加和慢性病负担的增加而成为增长最快的市场之一。

Sonde Health、Beyond Verbal、Cogito Corporation 和 Vocalis Health 等主要企业透过整合人工智慧技术来增强其语音/语音解决方案的功能，从而引领市场。

全球语音/言语生物标记市场的最新趋势

  • 6 月 25 日，Beyond Verbal 与梅奥诊所合作开发和检验用于早期阿兹海默症检测的声音生物标记。
  • 6月25日，Ellipsis Health 在A轮融资中筹集了4,500万美元，由Salesforce、Khosla Ventures和CVS Health Ventures领投。这笔投资旨在为其基于AI的语音助理提供支持，用于护理管理。
  • 2月25日，诺亚财富获得4,062.14亿美元融资，用于推进心臟病的远端监控和语音诊断。该公司正在探索透过分析语音音调变化，将人工智慧应用于基于语音的心臟诊断。
  • 12月22日，Sonde Health在B轮融资中完成1,925万美元，由Partners Investment领投，NEOM Company、KT Corporation、PureTech Health和M Ventures跟主要企业。目前，该公司已资金筹措3,525万美元，并计划加速全球扩张。
  • 8 月 22 日：Sonde Health 与 Koye Pharmaceuticals 达成多年期协议，共同开发印度慢性阻塞性肺病(COPD) 的语音生物标记检测和监测能力。

需求——驱动因素、挑战、机会

市场需求驱动因素

  • 扩大语音和言语生物标记作为新型诊断和监测辅助工具的应用

语音生物标记技术将彻底改变医疗保健产业。其非侵入性、经济高效且持续性的特性使其成为早期诊断、监测病情进展和管理各种健康状况的理想选择。透过利用语音特征的自然变化，临床医师可以深入了解患者原本难以察觉的健康状况。随着这些技术的不断发展，我们预计将在临床环境中得到更广泛的应用，尤其是在人工智慧演算法的改进以及监管核准简化语音生物标记与常规医疗保健的整合之后。语音生物标记技术作为一种创新的诊断和监测工具，正应用于各种临床领域。

神经病学 - 帕金森氏症、阿兹海默症和多发性硬化症等神经系统疾病通常会导致言语模式的细微变化。语音分析有助于发现这些疾病的早期症状并监测其进展。例如，声音震颤、音调和节奏的变化可能预示着帕金森氏症的运动障碍或失智症的认知衰退。

心理健康－忧郁症、焦虑和压力等心理健康状况会改变说话模式和语调。人工智慧演算法可以检测与这些状况相关的语音线索，例如语速减慢或语调平缓，从而促进持续监测和早期疗育。这使得被动、非侵入式筛检成为可能，例如透过简短的语音样本识别忧郁症风险。

心臟病学 - 研究表明，声音特征可以反映心血管健康状况。鼻塞或呼吸障碍引起的发声变化可能预示心臟衰竭或冠状动脉疾病。除了传统的心臟病早期检测和持续监测方法外，声音生物标记也正在被研究。

呼吸系统疾病－慢性阻塞性肺病(COPD) 和气喘等呼吸系统疾病会影响患者的声音和呼吸音。语音分析可以追踪患者的喘息、说话时的气短以及咳嗽模式，从而提供一种非侵入性的方式来监测呼吸系统健康并及早发现病情恶化。例如，语音生物标记物正在接受测试，透过分析语音记录来识别肺功能下降的征兆，从而帮助管理 COPD 患者。

其他临床应用—声音生物标记也正在被研究用于检测糖尿病併发症、认知障碍和创伤性脑损伤，以及监测高风险职业的压力和疲劳。在一般健康和预防医学领域，声音生物标记物提供了一种便捷的健康状况监测方法，例如一些健康应用程式可以追踪声音相关的压力水平，作为潜在健康问题的早期预警信号。

註：以上所有因素均在报告中进行了详细评估。

市场挑战

  • 技术限制和准确性问题

声音模式的多变性－人类的声音会因情绪状态、健康状况、环境噪音、年龄、性别、口音等因素而有很大差异。语音生物标记系统必须考虑这些变化，以确保准确可靠的辨识。

讯号品质－背景噪音（例如其他声音或环境声音）会扭曲音频讯号，使系统难以获得准确的生物特征资料。这在受控环境之外的现实环境中尤其具有挑战性。

即时处理－语音生物标记系统需要即时处理能力，这需要大量的运算资源。处理延迟或错误可能会导致错误识别和追踪，尤其是在客服中心和公共场所等高流量环境中。

阻碍语音/言语生物标记市场成长的其他挑战包括：

  • 缺乏标准化法规

市场机会

  • 使用语音/言语生物标记进行早期检测和预防疾病

语音/言语生物标记物提供了一种非侵入性且经济有效的方法，可早期发现各种健康状况，包括神经系统疾病（例如帕金森氏症、阿兹海默症）、心理健康问题（例如忧郁症、焦虑症）以及呼吸系统疾病（例如睡眠呼吸中止症、COVID-19）。早期检测有助于预防性护理和及时干预，从而改善患者预后并降低医疗成本。

Vocalis Health 利用人工智慧语音分析技术，透过分析语音模式的细微变化来检测帕金森氏症的征兆。让偏远地区和高风险族群更容易获得此类技术，从而实现早期疗育和个人化治疗方案，这蕴藏着巨大的潜力。同样，像 Sonde Health 这样的应用程式利用语音生物标记来监测情绪困扰，从而可以采取主动干预措施并预防慢性精神疾病。

创造市场成长机会的其他因素包括：

  • 语音/言语生物标记的临床试验数量不断增加

市场趋势

  • 将 AI/ML 整合到语音/声音生物标记技术中

人工智慧和机器学习与语音/语音生物标记技术的融合，代表着医疗保健诊断和监测能力的重大飞跃。这些技术不仅提供了非侵入式、即时和个人化的医疗保健解决方案，还为早期疾病检测、远端监测和预测分析开闢了新的途径。儘管资料隐私和临床检验的挑战依然存在，但人工智慧和机器学习透过语音生物标记彻底改变医疗保健的潜力巨大，将在各种健康状况的诊断和管理中带来显着益处。

本报告深入探讨了语音/言语生物标誌物的最新技术进步，使公司能够推动创新并开发出满足市场需求的尖端产品。

透过提供全面的市场分析和识别关键的成长机会，我们为公司提供知识来製定有针对性的行销策略并有效地扩大其市场占有率。

该报告包括全面的竞争格局分析，以帮助您了解语音/声音生物标记市场中竞争对手的优势和劣势，并制定有效的策略以在市场上获得竞争优势。

提供有关战略性声音/声音生物标誌物的法律规范、核准和行业指南的最新信息，使公司能够保持合规性并加速新声音/声音生物标誌物的市场进入。

透过分析市场趋势、资金筹措模式和合作机会，我们帮助公司做出明智的投资决策并发现潜在的併购机会以促进业务成长。

主要市场参与企业和竞争对手的摘要

公司简介是根据从主要专家收集的意见以及对公司覆盖范围、产品系列和市场渗透率的分析而选择的。

语音/语音生物标记市场涵盖了广泛的技术，旨在分析和解读语音数据，应用于从医疗诊断到客户服务中的情绪智商等各种领域。随着人工智慧和机器学习技术的持续进步，语音/语音生物标记市场预计将快速成长，并影响医疗保健、安防、汽车、客户服务和通讯等行业。随着人们对非侵入性诊断、个人化服务和增强安全性的日益关注，语音生物标记技术将在许多领域发挥关键作用，尤其是在医疗保健和语音身份验证领域拥有巨大的潜力。

在声音/声音生物标记市场中知名的公司有：

  • Sonde Health
  • Canary Speech
  • Ellipsis Health
  • auddering GmbH
  • Cogito Tech
  • Kintsugi
  • Beyond Verbal

目录

执行摘要

第一章全球语音生物标记市场：产业展望

  • 产业展望
  • 市场动态
  • 趋势

第二章 平台类型

  • 概述
  • 成长占有率矩阵
    • 云端基础的平台
  • 网路为基础的平台

第三章：申请类型

  • 概述
  • 成长占有率矩阵
    • 监控
    • 诊断
    • 临床研究
    • 其他的

第四章 适应症

  • 概述
  • 成长占有率矩阵
    • 精神障碍
    • 神经系统疾病
    • 呼吸系统疾病
    • 心血管疾病
    • 其他的

第五章 最终用户

  • 概述
  • 成长占有率矩阵
    • 医院
    • CRO
    • 研究所

第六章 区域

  • 北美洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 市场规模及预测
    • 美国
    • 加拿大
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 市场规模及预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 市场规模及预测
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 市场规模及预测
  • 中东和非洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 市场规模及预测

第七章：竞争格局与公司概况

  • 语音生物标记市场公司地位分析
  • 公司简介
    • audEERING GmbH
    • Biosensics
    • Canary Speech, Inc.
    • EVOCAL Health GmbH
    • Kintsugi Mindful Wellness, Inc.
    • PST Inc.
    • Sonde Health
    • Sound Health
    • VoiceMed Italia srl
    • Zana Technologies GmbH

第八章调查方法

Product Code: BHD3203SA

This report can be delivered within 1 working day.

Introduction of Voice/Vocal Biomarker Market

Voice/vocal biomarkers refer to the development, commercialization, and application of biological markers derived from human voice characteristics to detect, monitor, and predict health conditions. Voice/vocal biomarkers are a a part of digital biomarker and has measurable vocal features, such as pitch, tone, frequency, amplitude, speech rate, and tremor, which correlate with physiological or pathological states, enabling non-invasive diagnosis and monitoring. The voice/vocal biomarker market encompasses software platforms, AI and machine learning algorithms, hardware-enabled diagnostic tools, and integrated telehealth solutions that capture and analyze voice data to identify early signs of diseases including neurological disorders (e.g., Parkinson's, Alzheimer's), mental health conditions (e.g., depression, anxiety), respiratory illnesses, cardiovascular disease, and cognitive decline. It also covers applications in wellness, cognitive fitness, defense, and occupational health. Growth in this market has been fueled by technological advancements, the rising need for remote healthcare solutions, and the ability of vocal analysis to offer fast, scalable, and cost-effective screening compared to traditional diagnostic methods.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$1,243.5 Million
2035 Forecast$5,397.7 Million
CAGR15.81%

Market Introduction

The global voice/vocal biomarker market is expected to witness significant expansion, projected to reach 5,397.7 million by 2035.

Voice/vocal biomarkers are an emerging and innovative approach to diagnosing and monitoring various health conditions, primarily through the analysis of voice patterns and speech. The field is rapidly growing, with advancements in artificial intelligence (AI), machine learning, and natural language processing (NLP) enabling more accurate and non-invasive diagnostic tools.

Companies in the voice/vocal biomarker market like Sonde Health, Canary Speech, and Winterlight are leveraging AI-driven algorithms to analyze speech patterns for the detection of neurological, psychiatric, and cognitive disorders. These solutions assess vocal features such as pitch, tone, rhythm, and speed to identify early signs of diseases like Alzheimer's, Parkinson's, depression, and anxiety.

Voice/vocal biomarkers are being increasingly used to monitor cognitive impairment and other neurological conditions. The ability to detect subtle changes in voice and speech patterns allows for earlier interventions and more accurate disease progression tracking. This can significantly enhance the management of conditions like dementia and other age-related cognitive diseases.

One of the major advantages of vocal biomarker technology is its non-invasive nature. Unlike traditional diagnostic tools that require invasive procedures or extensive testing, vocal biomarkers use brief voice recordings (often just 30-40 seconds) to detect early indicators of health issues. This makes it a highly accessible tool for continuous monitoring, especially in remote settings.

Leading companies in the voice/vocal biomarker market space are forming strategic partnerships to enhance their capabilities and expand their market presence. For instance, Sonde Health has teamed up with Qualcomm to integrate its vocal biomarker technology into mobile platforms, enabling health monitoring through everyday devices. Additionally, Winterlight's acquisition by Cambridge Cognition highlights the growing emphasis on cognitive impairment detection via voice analysis.

The integration of vocal biomarker technology into healthcare systems is becoming more widespread, with applications in telemedicine, mental health, and cognitive health monitoring. These tools are increasingly being used in clinical settings, patient wellness programs, and research to track health status and detect early symptoms of diseases in a cost-effective and timely manner.

The voice/vocal biomarker market market is experiencing significant investment, driven by growing demand for innovative and non-invasive diagnostic solutions. Global voice/vocal biomarker market will continue to expand rapidly in the coming years, with applications not just limited to neurological and mental health but extending to chronic conditions like COPD and even detecting stress levels.

Despite the promising potential of vocal biomarkers, there are concerns around data privacy and the ethical use of voice data. As these technologies collect sensitive information about an individual's health, regulations like GDPR and HIPAA are essential to ensure privacy protection. Companies in the sector are focusing on ensuring that their solutions comply with data protection laws and that user data is securely handled.

In summary, global voice/vocal biomarker market positioning themselves as a transformative tool in healthcare, providing a non-invasive, accessible, and scalable solution for early detection and continuous monitoring of a wide array of health conditions. As technology advances, the integration of vocal biomarkers into everyday health applications is expected to significantly improve patient outcomes and healthcare efficiency.

Industrial Impact

Voice/vocal biomarker market are increasingly being used to monitor and diagnose a range of conditions such as neurodegenerative diseases (like Parkinson's or Alzheimer's), mental health disorders (like depression or anxiety), and respiratory diseases (such as asthma and COPD). For example, specific vocal changes can signal early-stage Parkinson's disease, which is traditionally difficult to diagnose early.

Voice-based Authentication: In industries where security and identity verification are paramount, vocal biomarkers are being used for voice biometrics. This involves analyzing a person's voice for unique characteristics (such as accent, tone, and speech rhythm) to authenticate identity. It's being adopted in banking, telecoms, and government sectors.

Impact: Improves security, reduces fraud, enhances user experience by enabling hands-free authentication.

In customer support, call centers, and virtual assistants (like Alexa or Siri), vocal biomarkers help detect emotions such as frustration, happiness, or stress. This allows companies to adapt responses accordingly or route customers to specialized agents based on their emotional state.

Market Segmentation

Segmentation 1: By Platform Type

  • Cloud-based
  • Web-based

Cloud-based remains the leading segment by platform type in the global voice/vocal Biomarker market, holding an 79.99% market share in 2024, with a projected CAGR of 16.0% during the forecast period 2025-2035.

Cloud-based platforms in the global voice/vocal biomarker market are transforming how voice data is collected, stored, processed, and analyzed. These platforms provide the infrastructure and computational power needed to process large volumes of speech data and apply AI algorithms for diagnostic and monitoring purposes. The emergence of cloud-based platforms for vocal biomarker analysis is reshaping the landscape of health diagnostics and remote patient monitoring. These platforms harness the power of AI and machine learning to interpret voice data, transforming vocal characteristics into actionable health insights. By leveraging scalable cloud infrastructure, they facilitate real-time, remote, and large-scale analysis, improving accessibility for clinicians, researchers, and digital health innovators.

Segmentation 2: By Indication Type

  • Neurological Disorder
  • Mental Health Disorder
  • Respiratory Diseases
  • Cardiovascular Disease
  • Others

Based on indication type, the global voice/vocal biomarker market was led by mental health disorder segment, which accounted for a 33.51% market share in 2024. Mental health disorders indication is dominating the voice/ vocal biomarkers market due to the increasing demand for non-invasive, real-time monitoring of emotional and psychological well-being. Voice analysis can detect stress, anxiety, depression, and other mental health conditions by analyzing tone, pitch, and speech patterns. For example, companies like Ellipsis Health have developed AI-powered platforms that assess mental health through voice recordings, enabling timely interventions and improving access to mental health care. This approach is gaining traction due to its ease of use and scalability.

Segmentation 3: By Application Type

  • Diagnostics
  • Monitoring
  • Clinical Research
  • Others

Based on application type, the global voice/vocal biomarker market market was led by diagnostics dominating the voice/ vocal biomarkers market. The diagnostics applications in the vocal biomarkers market is driven by the non-invasive nature of the technology, its ability to detect early signs of diseases, and its role in continuous monitoring of patient health. With advancements in AI, machine learning, and remote healthcare, vocal biomarkers provide a cost-effective, scalable, and accessible solution to improve the accuracy and timeliness of disease detection, particularly for neurological and respiratory conditions. As clinical validation progresses and the technology becomes more integrated into healthcare systems, the diagnostic applications of vocal biomarkers are expected to grow even further, offering significant benefits to both patients and healthcare providers.

Segmentation 4: By End User

  • Hospitals
  • CROs
  • Research Institutions

Based on end user, the global voice/vocal biomarker market market was led by the Hospitals and Clinics segment, which held a 47.02% share in 2024. Hospitals hold a dominant position in the vocal biomarker market, supported by several strategic strengths: their core involvement in diagnostics, expansive data repositories, mastery of regulatory frameworks, and robust financial backing combined with the trust they enjoy across healthcare networks. Their state-of-the-art infrastructure, cross-disciplinary synergies, and access to large patient populations make them optimal partners for the development, validation, and commercialization of vocal biomarker innovations. As these technologies evolve and gain maturity, hospitals are poised to remain at the forefront driving both clinical adoption and innovation in this emerging field.

Segmentation 5: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
  • Middle East and Africa

The global voice/vocal biomarker market market in the Asia-Pacific region is expanding rapidly. The voice/vocal biomarker market in APAC is poised for robust growth, particularly with the integration of AI and ML into mobile health devices, wearables, and telehealth services. However, regulatory frameworks and data privacy concerns need to be addressed to ensure long-term sustainability and widespread adoption.

With respect to countries of the APAC region, China holds the largest market share in the APAC region due to its large population and rapid technological adoption. India is emerging as one of the fastest-growing markets due to rising healthcare investments and an increasing burden of chronic diseases.

Companies such as Sonde Health, Beyond Verbal, Cogito Corporation, and Vocalis Health are leading the market by integrating AI technologies to enhance the capabilities of voice/vocal solutions..

Recent Developments in the Global Voice/Vocal Biomarker Market

  • In Jun-25: Beyond Verbal partnered with Mayo Clinic to develop and validate vocal biomarkers for early-stage Alzheimer's disease detection.
  • In Jun-25: Elipsis Health raised $45 million in Series A funding supported by Salesforce, Khosla Ventures, and CVS Health Ventures. This investment aims to enhance their AI-powered voice agents for care management
  • In Feb-25: Noah secured USD 406,214 Million to advance telemonitoring and voice diagnostics for heart diseases. Company explored the use of AI in voice-based diagnostics of heart diseases, analysing changes in vocal tone
  • In Dec-22: Sonde Health secured $19.25 million in Series B fundiing led by Partners Investment, with contributions from NEOM Company, KT Corporation, PureTech Health and M Ventures. With a total of $35.25 million raised, the company plans to use the capital to accelerate its global expansion.
  • In Aug-22: Sonde Health partnered with Koye Pharmaceuticals and entered a multi-year agreement to develop vocal biomarker detection and monitoring capabilities for Chronic Obstructive Pulmonary Disease (COPD) in India

Demand -Drivers, Challenges, and Opportunities

Market Demand Drivers:

  • Rising Application of Voice/Vocal Biomarkers as Novel Diagnostic and Monitoring Aid

Vocal biomarker technology represents a game-changer in the healthcare industry. Its non-invasive, cost-effective, and continuous nature makes it an attractive option for early diagnosis, monitoring disease progression, and managing various health conditions. By leveraging the natural variations in voice characteristics, clinicians can gain insights into a patient's health that would otherwise be difficult to detect. As these technologies continue to evolve, we can expect broader adoption across clinical settings, especially as AI algorithms improve and regulatory approvals streamline the integration of voice biomarkers into everyday healthcare. Vocal biomarker technology is being applied across various clinical domains as an innovative tool for diagnosis and monitoring.

Neurology: Neurological disorders such as Parkinson's disease, Alzheimer's, and multiple sclerosis often lead to subtle changes in voice patterns. Voice analysis can help detect early signs of these conditions or monitor their progression. For example, variations in vocal tremor, pitch, or timing may indicate motor impairments in Parkinson's disease or cognitive decline in dementia.

Mental Health: Mental health conditions, including depression, anxiety, and stress, can alter speech patterns and tone. AI algorithms can detect vocal cues, such as slower speech or flat intonation, associated with these conditions, facilitating continuous monitoring and early intervention. This allows for passive, non-intrusive screenings, such as identifying the risk of depression from a brief voice sample.

Cardiology: Research has shown that vocal characteristics can reflect cardiovascular health. Specific vocal patterns may be linked to heart conditions, with changes in speech due to congestion or breathing irregularities potentially signaling heart failure or coronary artery disease. Vocal biomarkers are being explored for early detection and ongoing monitoring of cardiac conditions alongside traditional methods.

Respiratory Disease: Respiratory conditions like chronic obstructive pulmonary disease (COPD) and asthma can affect voice and breathing sounds. Voice analysis can track wheezing, shortness of breath during speech, or coughing patterns, offering a non-invasive method to monitor respiratory health and detect exacerbations early. For example, vocal biomarkers are being tested to help manage COPD patients by analysing voice recordings to identify signs of declining lung function.

Other Clinical Uses: Vocal biomarkers are also being researched for detecting diabetic complications, cognitive impairments, traumatic brain injury, and monitoring stress or fatigue in high-risk professions. In general wellness and preventive care, vocal biomarkers provide a convenient way to monitor health, such as wellness apps tracking voice-derived stress levels as an early warning sign of potential health issues.

Note: All of the above factors will be evaluated in detail in the report.

Market Challenges:

  • Technology Limitations and Accuracy Issues

Variability in Voice Patterns: People's voices can vary widely based on factors like emotional state, health conditions, environmental noise, age, gender, and accent. Voice biomarker systems need to account for these variations to ensure accurate and reliable identification.

Signal Quality: Background noise, such as other voices or environmental sounds, can distort the voice signal, making it harder for the system to capture accurate biometric data. This is particularly challenging in real-world environments outside controlled settings.

Real-Time Processing: Voice biomarker systems require real-time processing capabilities, which can be computationally intensive. Delays or errors in processing may lead to incorrect identification or tracking, especially in high-traffic environments like call centers or public spaces.

Some of the other factors challenging the voice/vocal biomarker market growth include:

  • Lack of Standardized Regulation

Note: All of the above factors will be evaluated in detail in the report.

Market Opportunities:

  • Early Disease Detection and Prevention using Vocal Biomarkers

Voice/vocal biomarker provide a non-invasive and cost-effective means for early detection of a range of health conditions, including neurological disorders (e.g., Parkinson's disease, Alzheimer's disease), mental health issues (e.g., depression, anxiety), and respiratory conditions (e.g., sleep apnea, COVID-19). Early detection enables preventive care and timely interventions, which can lead to better patient outcomes and reduced healthcare costs.

Vocalis Health uses AI-powered voice analysis to detect signs of Parkinson's disease by analyzing subtle changes in speech patterns. The opportunity lies in scaling such technologies for widespread use in remote and at-risk populations, enabling earlier intervention and personalized treatment plans. Similarly, apps such as Sonde Health are leveraging vocal biomarkers to monitor emotional distress, which can indicate early signs of mental health conditions like depression and anxiety. This could lead to proactive interventions and the avoidance of chronic mental health conditions.

Some of the other factors creating an opportunity for market growth include:

  • Increasing Number of Clinical Trials on voice/vocal biomarker

Note: All of the above factors will be evaluated in detail in the report.

Market Trends:

  • Integration of AI/ML into Voice/Vocal Biomarker Technologies

The integration of AI and ML into voice/vocal biomarker technologies marks a significant leap forward in the diagnostic and monitoring capabilities of healthcare. These technologies not only provide non-invasive, real-time, and personalized healthcare solutions but also open up new avenues for early disease detection, remote monitoring, and predictive analytics. While challenges around data privacy and clinical validation remain, the potential for AI and ML to revolutionize healthcare through vocal biomarkers is immense, offering substantial benefits in the diagnosis and management of a wide array of health conditions.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in voice/vocal biomarker, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Voice/Vocal Biomarker and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Voice/Vocal Biomarker, ensuring organizations stay compliant and accelerate market entry for new voice/vocal biomarker

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on extensive interactions with experts and stakeholders across leading companies and research institutions worldwide. This report provides a comprehensive market analysis of robotics and non-robotics within the voice/vocal biomarker market.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available Voice/Vocal Biomarker products. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in Voice/Vocal Biomarker, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

The voice/vocal biomarker market encompasses a wide array of technologies designed to analyze and interpret voice data for various applications, from healthcare diagnostics to emotional intelligence in customer service. As technological advancements in AI and machine learning continue, the voice/vocal biomarker market is set to grow rapidly, impacting industries like healthcare, security, automotive, customer service, and telecommunications. With a growing focus on non-invasive diagnostics, personalized services, and enhanced security, vocal biomarker technologies are becoming a critical part of many sectors, with a particularly strong future in healthcare and voice authentication.

Some prominent names established in the voice/vocal biomarker market are:

  • Sonde Health
  • Canary Speech
  • Ellipsis Health
  • auddering GmbH
  • Cogito Tech
  • Kintsugi
  • Beyond Verbal

Table of Contents

Executive Summary

Scope and Definition

1 Global Voice/Vocal Biomarker Market: Industry Outlook

  • 1.1 Industry Outlook
    • 1.1.1 Market Overview and Ecosystem
      • 1.1.1.1 Future Direction and Emerging Technology
    • 1.1.2 Competitive Assessment
      • 1.1.2.1 Go-to-Market Strategy
      • 1.1.2.2 Competitive Landscape
        • 1.1.2.2.1 Business Strategies
    • 1.1.3 Opportunity Assessment
      • 1.1.3.1 Strategic Opportunities of Stakeholders in Voice/Vocal Biomarker Market
      • 1.1.3.2 Market Opportunity and Demand Analysis
    • 1.1.4 Funding Analysis
  • 1.2 Market Dynamics
    • 1.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • 1.3 Trends
    • 1.3.1 Integration of AI/ML into Vocal Biomarker Technologies
    • 1.3.2 Market Drivers
      • 1.3.2.1 Rising Application of Vocal Biomarkers as Novel Diagnostic and Monitoring Aid
      • 1.3.2.2 Increasing Demand for Remote and Non-Invasive Health Monitoring
      • 1.3.2.3 Adoption of Vocal Biomarkers in Health and Wellness Apps
    • 1.3.3 Market Restraints
      • 1.3.3.1 Regulatory Challenges and Unclear Guidelines
        • 1.3.3.1.1 Regulatory Approval for AI/ML-based Vocal Biomarker Applications
        • 1.3.3.1.2 Need for Clinical Validation
      • 1.3.3.2 Integration of Vocal Biomarker Technologies in Healthcare Systems and Associated Complexities
        • 1.3.3.2.1 Integration with EHR
        • 1.3.3.2.2 Integration with Telehealth Platforms
        • 1.3.3.2.3 Integration with Wearables and Smart Devices
    • 1.3.4 Market Opportunities
      • 1.3.4.1 Early Disease Detection and Prevention using Vocal Biomarkers
      • 1.3.4.2 Increasing Number of Clinical Trials and Research on Vocal Biomarker
    • 1.3.5 Market Challenges
      • 1.3.5.1 Technology Limitations and Accuracy Issues
      • 1.3.5.2 Lack of Standardized Regulations on Vocal Biomarker

2 Platform Type

  • 2.1 Overview
  • 2.2 Growth Share Matrix
    • 2.2.1 Cloud-Based Platform
  • 2.3 Web-Based Platform

3 Application Type

  • 3.1 Overview
  • 3.2 Growth Share Matrix
    • 3.2.1 Monitoring
    • 3.2.2 Diagnostics
    • 3.2.3 Clinical Research
    • 3.2.4 Others

4 Indication

  • 4.1 Overview
  • 4.2 Growth Share Matrix
    • 4.2.1 Mental Health Disorder
    • 4.2.2 Neurological Disorder
    • 4.2.3 Respiratory Diseases
    • 4.2.4 Cardiovascular Diseases
    • 4.2.5 Others

5 End User

  • 5.1 Overview
  • 5.2 Growth Share Matrix
    • 5.2.1 Hospitals
    • 5.2.2 CROs
    • 5.2.3 Research Institutions

6 Region

  • 6.1 North America
    • 6.1.1 Regional Overview
    • 6.1.2 Driving Factors for Market Growth
    • 6.1.3 Factors Challenging the Market
    • 6.1.4 Market Sizing and Forecast
      • 6.1.4.1 North America Voice/Vocal Biomarkers Market, by Platform Type
      • 6.1.4.2 North America Voice/Vocal Biomarkers Market, by Application
      • 6.1.4.3 North America Voice/Vocal Biomarkers Market, by Indication
      • 6.1.4.4 North America Voice/Vocal Biomarkers Market, by End User
      • 6.1.4.5 North America Voice/Vocal Biomarkers Market, by Country
    • 6.1.5 U.S.
      • 6.1.5.1 Country Overview
        • 6.1.5.1.1 Market Sizing and Forecast
    • 6.1.6 Canada
      • 6.1.6.1 Country Overview
        • 6.1.6.1.1 Market Sizing and Forecast
  • 6.2 Europe
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 Market Sizing and Forecast
      • 6.2.4.1 Europe Voice/Vocal Biomarkers Market, by Platform Type
      • 6.2.4.2 Europe Voice/Vocal Biomarkers Market, by Application
      • 6.2.4.3 Europe Voice/Vocal Biomarkers Market, by Indication
      • 6.2.4.4 Europe Voice/Vocal Biomarkers Market, by End User
      • 6.2.4.5 Europe Voice/Vocal Biomarkers Market, by Country
    • 6.2.5 U.K.
      • 6.2.5.1 Country Overview
        • 6.2.5.1.1 Market Sizing and Forecast
    • 6.2.6 Germany
      • 6.2.6.1 Country Overview
        • 6.2.6.1.1 Market Sizing and Forecast
    • 6.2.7 France
      • 6.2.7.1 Country Overview
        • 6.2.7.1.1 Market Sizing and Forecast
    • 6.2.8 Italy
      • 6.2.8.1 Country Overview
        • 6.2.8.1.1 Market Sizing and Forecast
    • 6.2.9 Spain
      • 6.2.9.1 Country Overview
        • 6.2.9.1.1 Market Sizing and Forecast
    • 6.2.10 Rest-of-the- Europe
      • 6.2.10.1 Country Overview
        • 6.2.10.1.1 Market Sizing and Forecast
  • 6.3 Asia-Pacific
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 Market Sizing and Forecast
      • 6.3.4.1 Asia-Pacific Voice/Vocal Biomarkers Market, by Platform Type
      • 6.3.4.2 Asia-Pacific Voice/Vocal Biomarkers Market, by Application
      • 6.3.4.3 Asia-Pacific Voice/Vocal Biomarkers Market, by Indication
      • 6.3.4.4 Asia-Pacific Voice/Vocal Biomarkers Market, by End User
      • 6.3.4.5 Asia-Pacific Voice/Vocal Biomarkers Market, by Country
    • 6.3.5 China
      • 6.3.5.1 Country Overview
        • 6.3.5.1.1 Market Sizing and Forecast
    • 6.3.6 Japan
      • 6.3.6.1 Country Overview
        • 6.3.6.1.1 Market Sizing and Forecast
    • 6.3.7 India
      • 6.3.7.1 Country Overview
        • 6.3.7.1.1 Market Sizing and Forecast
    • 6.3.8 Australia
      • 6.3.8.1 Country Overview
        • 6.3.8.1.1 Market Sizing and Forecast
    • 6.3.9 South Korea
      • 6.3.9.1 Country Overview
        • 6.3.9.1.1 Market Sizing and Forecast
    • 6.3.10 Rest-of-the- Asia-Pacific
      • 6.3.10.1 Country Overview
        • 6.3.10.1.1 Market Sizing and Forecast
  • 6.4 Latin America
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 Market Sizing and Forecast
      • 6.4.4.1 Latin America Voice/Vocal Biomarkers Market, by Platform Type
      • 6.4.4.2 Latin America Voice/Vocal Biomarkers Market, by Application
      • 6.4.4.3 Latin America Voice/Vocal Biomarkers Market, by Indication
      • 6.4.4.4 Latin America Voice/Vocal Biomarkers Market, by End User
  • 6.5 Middle East and Africa
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 Market Sizing and Forecast
      • 6.5.4.1 Middle East and Africa Voice/Vocal Biomarkers Market, by Platform Type
      • 6.5.4.2 Middle East and Africa Voice/Vocal Biomarkers Market, by Application
      • 6.5.4.3 Middle East and Africa Voice/Vocal Biomarkers Market, by Indication
      • 6.5.4.4 Middle East and Africa Voice/Vocal Biomarkers Market, by End User

7 Competitive Landscape and Company Profiles

  • 7.1 Company Position Analysis in Voice/Vocal Biomarkers Market
  • 7.2 Company Profiles
    • 7.2.1 audEERING GmbH
      • 7.2.1.1 Overview
    • 7.2.2 Biosensics
      • 7.2.2.1 Overview
    • 7.2.3 Canary Speech, Inc.
      • 7.2.3.1 Overview
    • 7.2.4 EVOCAL Health GmbH
      • 7.2.4.1 Overview
    • 7.2.5 Kintsugi Mindful Wellness, Inc.
      • 7.2.5.1 Overview
    • 7.2.6 PST Inc.
      • 7.2.6.1 Overview
    • 7.2.7 Sonde Health
      • 7.2.7.1 Overview
    • 7.2.8 Sound Health
      • 7.2.8.1 Overview
    • 7.2.9 VoiceMed Italia srl
      • 7.2.9.1 Overview
    • 7.2.10 Zana Technologies GmbH
      • 7.2.10.1 Overview

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Inclusion and Exclusion
    • 8.1.4 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Voice/Vocal Biomarker Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Global Voice/Vocal Biomarker Market, 2024-2035
  • Figure 3: Top 10 Countries, Global Voice/Vocal Biomarker Market, $Million, 2024
  • Figure 4: Global Voice/Vocal Biomarker Market Snapshot
  • Figure 5: Global Voice/Vocal Biomarker Market, $Million, 2024 and 2035
  • Figure 6: Voice/Vocal Biomarker Market (by Platform Type), $Million, 2024, 2028, and 2035
  • Figure 7: Voice/Vocal Biomarker Market (by Application Type), $Million, 2024, 2028, and 2035
  • Figure 8: Voice/Vocal Biomarker Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 9: Voice/Vocal Biomarker Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 10: Voice/Vocal Biomarker Market Segmentation
  • Figure 11: Go-to-Market Strategy of Major Players
  • Figure 12: Go-to-Market Strategy of Major Players
  • Figure 13: Go-to-Market Strategy of Major Players
  • Figure 14: Companies Offering AI-based Vocal Biomarkers for Early Disease Detection
  • Figure 15: Global Voice/Vocal Biomarkers Market, by Platform Type, $Million, 2024, 2028, and 2035
  • Figure 16: Key Value Propositions of Cloud-Based Vocal Biomarker Platforms
  • Figure 17: Cloud-based Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 18: Web-Based Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 19: Global Voice/Vocal Biomarker Market, by Patient Type, $Million, 2024, 2028, and 2035
  • Figure 20: Global Voice/Vocal Biomarker Market, by Monitoring, $Million, 2024-2035
  • Figure 21: Global Voice/Vocal Biomarker Market, by Diagnostics, $Million, 2024-2035
  • Figure 22: Global Voice/Vocal Biomarker Market, by Clinical Research, $Million, 2024-2035
  • Figure 23: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
  • Figure 24: Global Voice/Vocal Biomarker Market, by Indication, $Million, 2024, 2028, and 2035
  • Figure 25: Global Voice/Vocal Biomarker Market, by Mental Health Disorder, $Million, 2024-2035
  • Figure 26: Global Voice/Vocal Biomarker Market, by Neurological Disorder, $Million, 2024-2035
  • Figure 27: Global Voice/Vocal Biomarker Market, by Respiratory Diseases, $Million, 2024-2035
  • Figure 28: Global Voice/Vocal Biomarker Market, by Cardiovascular Diseases, $Million, 2024-2035
  • Figure 29: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
  • Figure 30: Global Voice/Vocal Biomarker Market, by End User, $Million, 2024, 2028, and 2035
  • Figure 31: Global Voice/Vocal Biomarker Market, by Hospitals, $Million, 2024-2035
  • Figure 32: Global Voice/Vocal Biomarker Market, by CROs, $Million, 2024-2035
  • Figure 33: Global Voice/Vocal Biomarker Market, by Research Institutions, $Million, 2024-2035
  • Figure 34: North America Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 35: U.S. Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 36: Canada Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 37: Europe Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 38: U.K. Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 39: Germany Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 40: France Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 41: Italy Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 42: Spain Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 43: Rest-of-the Europe Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 44: Asia Pacific Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 45: China Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 46: Japan Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 47: India Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 48: Australia Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 49: South-Korea Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 50: Rest-of-the Asia-Pacific Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 51: Latin America Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 52: Middle East and Africa Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 53: Inclusion and Exclusion Criteria for Global Voice/Vocal Biomarker Market
  • Figure 54: Data Triangulation
  • Figure 55: Top-Down and Bottom-Up Approach
  • Figure 56: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Recent Funding in Global Voice/Vocal Biomarker Market
  • Table 3: Use of AI/ML Technology by Companies
  • Table 4: Key Market Players and their Major Contributions
  • Table 5: Few Clinical Trials Related to Voice Biomarker
  • Table 6: Companies using Platform for Voice/Vocal Biomarker
  • Table 7: Global Voice/Vocal Biomarkers Market (by Region), $Million, 2024-2035
  • Table 8: North America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 9: North America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 10: North America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 11: North America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 12: North America Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 13: Europe Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 14: Europe Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 15: Europe Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 16: Europe Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 17: Europe Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 18: Asia-Pacific Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 19: Asia-Pacific Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 20: Asia-Pacific Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 21: Asia-Pacific Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 22: Asia-Pacific Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 23: Latin America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 24: Latin America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 25: Latin America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 26: Latin America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 27: Middle East and Africa Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 28: Middle East and Africa Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 29: Middle East and Africa Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 30: Middle East and Africa Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035